PUBLISHER: The Business Research Company | PRODUCT CODE: 1694734
PUBLISHER: The Business Research Company | PRODUCT CODE: 1694734
Pediatric heart valve repair and replacement encompass medical procedures and technologies utilized to address heart valve issues in children, particularly targeting congenital or acquired heart valve disorders. These procedures are essential for treating conditions such as congenital heart defects, heart muscle disease, arrhythmias, and atresia.
The primary products in pediatric heart valve repair and replacement include heart valve repair, mechanical heart valves, bioprosthetic heart valves, and transcatheter aortic valve implantation (TAVI). Heart valve repair involves restoring the normal function of a malfunctioning heart valve through medical intervention. This procedure is indicated for various cardiac disorders, including congenital heart defects, heart muscle disease, atresia, arrhythmias, among others. The end-users of these products typically include hospitals, independent cardiac catheterization labs, and ambulatory surgical centers.
The pediatric heart valve repair and replacement market research report is one of a series of new reports from The Business Research Company that provides pediatric heart valve repair and replacement market statistics, including pediatric heart valve repair and replacement industry global market size, regional shares, competitors with a pediatric heart valve repair and replacement market share, detailed pediatric heart valve repair and replacement market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric heart valve repair and replacement industry. This pediatric heart valve repair and replacement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pediatric heart valve repair and replacement market size has grown steadily in recent years. It will grow from $3.36 billion in 2024 to $3.49 billion in 2025 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to increasing prevalence of congenital heart defects, growing awareness and early diagnosis, supportive regulatory environment, rising healthcare investments, and patient and parent advocacy.
The pediatric heart valve repair and replacement market size is expected to see steady growth in the next few years. It will grow to $3.86 billion in 2029 at a compound annual growth rate (CAGR) of 2.5%. The growth in the forecast period can be attributed to increased incidence of pediatric cardiovascular conditions, expanded access to pediatric cardiac care, growing emphasis on early intervention, rise in pediatric cardiovascular research, and global healthcare infrastructure development. Major trends in the forecast period include growing adoption of tissue-engineered heart valves, pediatric-specific device innovation, expansion of hybrid approaches, rising application of 3d printing technology, and pediatric valve-in-valve procedures.
The rising prevalence of congenital heart defects is anticipated to drive the growth of the pediatric heart valve repair and replacement market in the future. A congenital heart defect (CHD) refers to an abnormality in the heart's structure that is present at birth. Pediatric heart valve repair and replacement are utilized in treating congenital heart defects to enhance heart function, improve the overall health of the child, prevent complications, and enhance the quality of life for those affected. For example, in October 2024, reports from the Centers for Disease Control and Prevention, a US-based national public health agency, indicated that heart defects impact nearly 1% of births-approximately 40,000 infants-each year in the United States. About 1 in 4 babies with a heart defect are diagnosed with a critical heart defect. In 2023, a baby was born with a heart defect in America every 15 minutes. Therefore, the increasing incidence of congenital heart defects is expected to stimulate growth in the pediatric heart valve repair and replacement market.
Major companies within the pediatric heart valve repair and replacement industry are embracing a strategic partnership approach to deliver customized solutions that cater to the distinct requirements of pediatric cardiac care. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and success. For example, in August 2023, PolyVascular Inc., a US-based medical technology manufacturer, joined forces with CobiCure, a US-based not-for-profit organization focused on pediatric care. Through this collaboration, their aim is to advance pediatric heart valve repair by offering a tailored, non-surgical approach to address congenital heart defects in children. By eliminating the need for multiple open-heart surgeries as children outgrow traditional valves, they seek to minimize associated complications and enhance patient outcomes.
In July 2024, Edwards Lifesciences, a medical technology company based in the US, acquired Innovalve Bio Medical Ltd. for an undisclosed sum. This acquisition is intended to enhance the company's transcatheter mitral valve replacement (TMVR) technologies to address significant unmet needs among structural heart patients and support sustainable long-term growth. Innovalve Bio Medical Ltd. is an Israel-based developer of TMVR technology and cardiac valves.
Major companies operating in the pediatric heart valve repair and replacement market report are Abbott Laboratories, Medtronic plc, Labcor Laboratorios Ltda, Boston Scientific Corporation, Bracco Group, Lepu Medical Technology (Beijing) Co. Ltd., Edwards Lifesciences Corporation, Artivion Inc., CryoLife Inc., LivaNova PLC, TTK Healthcare Limited, Braile Biomedica Ltda., Arbor Surgical Technologies Inc., Micro Interventional Devices Inc., Xeltis AG, Auto Tissue Berlin GmbH, BioStable Science and Engineering Inc., Colibri Heart Valve LLC, Valcare Medical, Symetis SA, Neovasc Inc., Aortech international Plc., On-X Life Technologies Holdings Inc., JenaValve Technology Inc., Meril Life Sciences Pvt. Ltd.
North America was the largest region in the pediatric heart valve repair and replacement market in 2024. The regions covered in the pediatric heart valve repair and replacement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pediatric heart valve repair and replacement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pediatric heart valve repair and replacement market includes revenues earned by providing services such as diagnosis and evaluation, treatment planning, medical management, surgical intervention and surgery. The market value includes the value of related goods sold by the service provider or included within the service offering. The pediatric heart valve repair and replacement market also consists of sales of biological valves, postoperative monitoring devices, sutures and repair materials, annuloplasty rings and bands, and annuloplasty rings and bands. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pediatric Heart Valve Repair And Replacement Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on pediatric heart valve repair and replacement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pediatric heart valve repair and replacement ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pediatric heart valve repair and replacement market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.